Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Shuangyong Road No.6, Nanning, Guangxi, China.
J Transl Med. 2023 Oct 9;21(1):707. doi: 10.1186/s12967-023-04596-4.
Seizures are associated with a decrease in γ-aminobutyric type A acid receptors (GABAaRs) on the neuronal surface, which may be regulated by enhanced internalization of GABAaRs. When interactions between GABAaR subunit α-1 (GABRA1) and postsynaptic scaffold proteins are weakened, the α1-containing GABAaRs leave the postsynaptic membrane and are internalized. Previous evidence suggested that neuroplastin (NPTN) promotes the localization of GABRA1 on the postsynaptic membrane. However, the association between NPTN and GABRA1 in seizures and its effect on the internalization of α1-containing GABAaRs on the neuronal surface has not been studied before.
An in vitro seizure model was constructed using magnesium-free extracellular fluid, and an in vivo model of status epilepticus (SE) was constructed using pentylenetetrazole (PTZ). Additionally, in vitro and in vivo NPTN-overexpression models were constructed. Electrophysiological recordings and internalization assays were performed to evaluate the action potentials and miniature inhibitory postsynaptic currents of neurons, as well as the intracellular accumulation ratio of α1-containing GABAaRs in neurons. Western blot analysis was performed to detect the expression of GABRA1 and NPTN both in vitro and in vivo. Immunofluorescence co-localization analysis and co-immunoprecipitation were performed to evaluate the interaction between GABRA1 and NPTN.
The expression of GABRA1 was found to be decreased on the neuronal surface both in vivo and in vitro seizure models. In the in vitro seizure model, α1-containing GABAaRs showed increased internalization. NPTN expression was found to be positively correlated with GABRA1 expression on the neuronal surface both in vivo and in vitro seizure models. In addition, NPTN overexpression alleviated seizures and NPTN was shown to bind to GABRA1 to form protein complexes that can be disrupted during seizures in both in vivo and in vitro models. Furthermore, NPTN was found to inhibit the internalization of α1-containing GABAaRs in the in vitro seizure model.
Our findings provide evidence that NPTN may exert antiepileptic effects by binding to GABRA1 to inhibit the internalization of α1-containing GABAaRs.
癫痫发作会导致神经元表面 γ-氨基丁酸 A 型受体(GABAaRs)减少,这可能是 GABAaRs 内化增强所致。当 GABAaR 亚基 α-1(GABRA1)与突触后支架蛋白的相互作用减弱时,含 α1 的 GABAaRs 离开突触后膜并被内化。先前的证据表明神经可塑性蛋白(NPTN)促进 GABRA1 在突触后膜的定位。然而,NPTN 与癫痫发作中 GABRA1 的关联及其对神经元表面含 α1 的 GABAaRs 内化的影响尚未被研究过。
使用无镁细胞外液构建体外癫痫发作模型,使用戊四氮(PTZ)构建体内癫痫持续状态(SE)模型。此外,还构建了体外和体内 NPTN 过表达模型。进行电生理记录和内化测定,以评估神经元动作电位和微小抑制性突触后电流以及神经元内含 α1 的 GABAaRs 的细胞内积累比。进行 Western blot 分析以检测体外和体内 GABRA1 和 NPTN 的表达。进行免疫荧光共定位分析和免疫共沉淀,以评估 GABRA1 和 NPTN 之间的相互作用。
在体内和体外癫痫发作模型中,均发现神经元表面 GABRA1 的表达减少。在体外癫痫发作模型中,含 α1 的 GABAaRs 内化增加。NPTN 表达与体内和体外癫痫发作模型中神经元表面 GABRA1 的表达呈正相关。此外,NPTN 过表达可减轻癫痫发作,并且 NPTN 被发现与 GABRA1 结合形成蛋白复合物,该复合物可在体内和体外模型中被癫痫发作破坏。此外,NPTN 被发现可抑制体外癫痫发作模型中含 α1 的 GABAaRs 的内化。
我们的研究结果提供了证据,表明 NPTN 可能通过与 GABRA1 结合抑制含 α1 的 GABAaRs 的内化来发挥抗癫痫作用。